Latest News about AZN
Recent news which mentions AZN
3 Magnificent Growth Stocks to Buy Right Now
September 24, 2023
From Motley Fool
Pfizer maternal RSV vaccine recommended by CDC advisers
September 22, 2023
From MarketWatch
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
From Benzinga
Scholastic stock tumbles on loss, Activision share rises on Microsoft deal news and more moving stocks
September 22, 2023
From MarketWatch
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 15, 2023
From Benzinga
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
From Benzinga
From Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
From Benzinga
4 Top-Tier Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 09, 2023
From Motley Fool
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population
September 06, 2023
From Benzinga
FDA Seeks Further Safeguards for AstraZeneca's Ultomiris Therapy, But Efficacy Not in Question
September 06, 2023
Tickers
AZN
From Benzinga
3 Forever Stocks to Buy With $100
September 05, 2023
From Motley Fool
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
From Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
From Benzinga
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
September 02, 2023
From Motley Fool
From Benzinga
From Motley Fool
From MarketWatch
From Benzinga
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
From Benzinga
Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government
August 25, 2023
From Benzinga
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
August 25, 2023
From InvestorPlace
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
From Benzinga
From Benzinga
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.